MAP3K14 and diabetes mellitus: In another study, Todorova et al. included 119 diabetic patients (41 with IDFU, 35 with non-IDFU, and 43 with diabetes alone) and also demonstrated that Hs-CRP significantly outperformed procalcitonin in distinguishing infected from non-IDFU (19).